VelaLabs – A Tentamus Company now offers Analyses of Leachables & Extractables

In order to enlarge the service portfolio for our customers in the pharma sector Tentamus has invested in new analytical instruments. A state-of-the-art UHPLC coupled with a high resolution Q-TOF MS allows both identification and quantitation of leachable and extractable and a reliable prediction of sum formulas. Subsequently the MS/MS spectra of compounds of interest are compared with databases or reference standards. In combination with the ability to quantify, a comprehensive summary can be created and used as the basis for toxicological assessment. This further development enables the Tentamus Laboratories to offer a full one stop shop to the pharmaceutical industry.

Due to the high acquisition speed of the instrument a special algorithm collects all information, including intact mass and fragment spectra in a single run. This opens the possibility to retrospectively evaluate already measured samples and screen for certain substances without the necessity of a re-measurement, or worse, repeating of a study if a critical component is discovered during a later assessment by a toxicologist.

Furthermore a GC/MS device with a versatile automatic sample handler is in place. This allows the analysis of volatile and non-volatile compounds and therefore the conduction of all common L&E analyses is possible.

To ensure the highest level of data integrity all instruments operate under GxP.

About Tentamus Group

Tentamus Group GmbH was founded in 2011. Tentamus is a global product and safety group with a core presence in Europe, UK, Israel, China and the USA. Accredited and licensed Tentamus Group tests, audits and consults on all products involving the human body (food & feed, pharmaceuticals & medical, agrochemicals, cosmetics, agriculture & environment and nutraceutical & supplements). Tentamus Group is represented in over 30 locations worldwide. More than 1,600 highly-trained staff members work in over 1 million square feet of laboratory and office spaces. For further information please visit

About VelaLabs

VelaLabs is a world -wide acting, GMP-certified and GCLP-compliant contract laboratory that offers in-depth analytical characterization services for proteins including biopharmaceuticals, biosimilars, biologics and peptides. Combining a focused, customer-orientated approach, a highly motivated team and a broad expertise in analytical development and quality control, VelaLabs is dedicated to support customer’s needs from research activities to clinical phases up to product commercialization and market release.

VelaLabs GmbH
Brunner Strasse 69/3
1230 Wien / Austria

Contact: Markus Roucka
Tel: +43 (0) 1 890 5979 11

Firmenkontakt und Herausgeber der Meldung:

Tentamus Group GmbH
An der Industriebahn 5
13088 Berlin
Telefon: +49 (30) 206038-230
Telefax: +49 (30) 206038-190

Dr. Yvonne Pfeifer
Director Business Development
Telefon: +49 (30) 206038164
Für die oben stehende Pressemitteilung ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.